empty
 
 
Pfizer to make $15 billion from Covid-19 vaccine sales
17-02-2021 17:22
Pfizer to make $15 billion from Covid-19 vaccine sales
Pfizer to make $15 billion from Covid-19 vaccine sales

According to Reuters, US pharmaceutical company Pfizer Inc is expected to generate $15 billion this year from sales of the Covid-19 vaccine developed in cooperation with its German partner BioNTech. In the fourth quarter of 2020, the revenue from vaccine sales came in at $154 million, while consensus estimates provided by Mizuho financial group suggested that it would amount to $462 million. In its report published on February 9, Pfizer projects its overall revenue to be between $59.4 billion and $61.4 billion this year. The company has also raised its yearly adjusted profit forecast to $3.10–$3.20 per share. Previously, Pfizer expected to earn $3.00–$3.10 per share.

*The market analysis posted here is meant to increase your awareness, but not to give instructions to make a trade.

  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST
  • Chancy Deposit
    Deposit your account with $3,000 and get $10000 more!
    In January we raffle $10000 within the Chancy Deposit campaign!
    Get a chance to win by depositing $3,000 to a trading account. Having fulfilled this condition, you become a campaign participant.
    JOIN CONTEST
  • Trade Wise, Win Device
    Top up your account with at least $500, sign up for the contest, and get a chance to win mobile devices.
    JOIN CONTEST
  • 30% Bonus
    Receive a 30% bonus every time you top up your account
    GET BONUS
Can't speak right now?
Ask your question in the chat.
Widget callback